FIELD: medicine, endocrinology. SUBSTANCE: invention relates to insulin-induced obesity. Invention proposes to administrate additionally amyline or amyline agonist to a patient using insulin, in part, in diabetes mellitus. Method provides reduction of patient weight that relieves the disease course significantly. EFFECT: enhanced effectiveness of treatment. 6 cl, 8 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OR PROPHYLAXIS OF OBESITY | 2002 |
|
RU2314121C9 |
| METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
| ANALOG-AGONIST OF AMYLINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION EXHIBITING PROPERTIES OF AMYLINE AGONIST | 1992 |
|
RU2130463C1 |
| METHOD FOR TREATING DIABETES TYPE II WITH AMYLENE ANTAGONISTS | 1996 |
|
RU2166958C2 |
| NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
| METHODS OF DIABETES TREATMENT AND BODY WEIGHT REDUCTION | 2006 |
|
RU2421237C2 |
| PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
| METHODS OF REGULATION OF GASTROENTERIC TRACT MOTOR SYSTEM | 1994 |
|
RU2177331C2 |
| METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS | 2004 |
|
RU2543350C2 |
| METHODS AND COMPOSITIONS FOR GASTROENTERIC UPSET THERAPY | 2004 |
|
RU2353383C2 |
